Caricamento...
Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators
In the last two years, clinical trials with blocking antibodies to the negative checkpoint regulators CTLA-4 and PD-1 have rekindled the hope for cancer immunotherapy. Multiple negative checkpoint regulators protect the host against autoimmune reactions but also restrict the ability of T cells to ef...
Salvato in:
| Pubblicato in: | Front Immunol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4544156/ https://ncbi.nlm.nih.gov/pubmed/26347741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2015.00418 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|